Fluorouracil

UDP glucuronosyltransferase family 1 member A1 ; Homo sapiens







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31558477 Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype-Guided Dosing. 2020 Jan 1 1
2 30447099 Impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX. 2019 Feb 1
3 29487697 DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer. 2018 Jan 30 1
4 30498448 Clinical Value of Pharmacogenomic Testing in a Patient Receiving FOLFIRINOX for Pancreatic Adenocarcinoma. 2018 2
5 30538568 Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28. 2018 4
6 27641154 Genotypes Affecting the Pharmacokinetics of Anticancer Drugs. 2017 Apr 1
7 27461651 DPYD*2A/*5A/*9A and UGT1A1*6/*28 polymorphisms in Chinese colorectal cancer patients. 2016 Apr-Jun 1
8 23529007 Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians. 2014 Apr 2
9 23236239 UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil. 2012 Dec 7 2
10 20513938 Pharmacogenetic application in personalized cancer treatment. 2010 Apr 2
11 20637356 [Recent developments of pharmacogenomics in the treatment of colorectal cancers]. 2010 Jul 1
12 17273745 Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan. 2007 Mar 2
13 17016579 Irinotecan cytotoxicity does not necessarily depend on the UGT1A1 polymorphism but on fluoropyrimidine: a molecular case report. 2006 Nov 2
14 15858133 5-Fluorouracil/irinotecan induced lethal toxicity as a result of a combined pharmacogenetic syndrome: report of a case. 2005 May 1